What's breaking now, across thousands of outlets.
MADRID — Roche’s next-gen KRAS G12C inhibitor cut the risk of death by 44% in previously treated mutant non-small cell lung cancer in a head-to-head trial against drugs with the same target from Amgen and Bristol ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
MADRID — AstraZeneca said Sunday it might have found a way for patients with mutant non-small cell lung cancer to keep taking Tagrisso even after they have become resistant to the EGFR-targeting…
Rajatpal Singh, a patient at a Kharar hospital, allegedly assaulted a medical officer and damaged property. The violent incident occurred during treatment when Singh attacked the doctor and a nurse.
How a group of young radicals helped set Aneurin Bevan on the path to founding the NHS.
Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death by 42% and the overall risk of death by 44%, in the…
Pope Leo says he is also praying for those killed and wounded in the 'terrorist attack against Orthodox faithful' at Hamoud church in Jordan.
Pope Leo says he is also praying for those killed and wounded in the 'terrorist attack against Orthodox faithful' at Hamoud church in Jordan.
